Ubs Group Ag Tivic Health Systems, Inc. Transaction History

Ubs Group Ag

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.09 - $0.19 $9,291 - $19,615	-103,241 Reduced 77.71%	29,619 $3,000
Q1 2023 May 12, 2023	BUY	$0.15 - $0.83 $19,390 - $107,293	129,269 Added 3599.81%	132,860 $19,000
Q4 2022 Feb 08, 2023	SELL	$0.61 - $175.5 $397 - $114,250	-651 Reduced 15.35%	3,591 $2,000
Q3 2022 Nov 10, 2022	BUY	$1.49 - $145.0 $3,002 - $292,175	2,015 Added 90.48%	4,242 $6,000
Q2 2022 Aug 10, 2022	BUY	$1.4 - $2.4 $3,117 - $5,344	2,227 New	2,227 $4,000
Q1 2022 May 16, 2022	SELL	$1.31 - $4.05 $5,914 - $18,285	-4,515 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.49 - $5.58 $15,757 - $25,193	4,515 New	4,515 $18,000

Ticker TIVC
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 9,677,730
Market Cap $2.61M
Description
Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own w...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.